Mutations of Kit at position D816 have been implicated in mastocytosis, acute myeloid leukaemia and germ cell tumours. Expression of this mutant Kit in cell lines results in factor-independent growth, differentiation and increased survival in vitro and tumourigenicity in vivo. Mutant D816VKit and wild-type Kit were expressed in murine primary haemopoietic cells and grown in stem cell factor (SCF) or the absence of factors. Expression of D816VKit did not lead to transformation as assessed by a colony assay, but resulted in enhanced differentiation of cells when compared to control cells. D816VKit induced an increase in the number of cells differentiating along the megakaryocyte lineage in the absence of factors. SCF had an added effect with ...
<div><p>Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mas...
Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematol...
D816V KIT mutation of bone marrow (BM) mast cells (MC) is a common feature to systemic mastocytosis ...
Mutations of Kit at position D816 have been implicated in mastocytosis, acute myeloid leukaemia and ...
Stem cell factor (SCF) binds the receptor tyrosine kinase c-Kit and is critical for normal hematopoi...
The cDNAs encoding wild type (WT) human receptor tyrosine kinase c-Kit and a constitutively activate...
The primary role of protooncogene c-kit in mast cell differentiation is supported by the development...
Mastocytosis is a rare neoplastic disease characterized by a pathologic accumulation of tissue mast ...
Background: Systemic mastocytosis (SM) is a haematological disease characterised by organ infiltrati...
Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hem...
KIT is a receptor tyrosine kinase that is functionally relevant for hematopoiesis, mast cell develop...
Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hem...
International audienceThe D816V-mutated variant of Kit triggers multiple signaling pathways and is c...
Multilineage involvement of bone marrow (BM) hematopoiesis by the somatic KIT D816V mutation is pres...
Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mast cells ...
<div><p>Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mas...
Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematol...
D816V KIT mutation of bone marrow (BM) mast cells (MC) is a common feature to systemic mastocytosis ...
Mutations of Kit at position D816 have been implicated in mastocytosis, acute myeloid leukaemia and ...
Stem cell factor (SCF) binds the receptor tyrosine kinase c-Kit and is critical for normal hematopoi...
The cDNAs encoding wild type (WT) human receptor tyrosine kinase c-Kit and a constitutively activate...
The primary role of protooncogene c-kit in mast cell differentiation is supported by the development...
Mastocytosis is a rare neoplastic disease characterized by a pathologic accumulation of tissue mast ...
Background: Systemic mastocytosis (SM) is a haematological disease characterised by organ infiltrati...
Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hem...
KIT is a receptor tyrosine kinase that is functionally relevant for hematopoiesis, mast cell develop...
Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hem...
International audienceThe D816V-mutated variant of Kit triggers multiple signaling pathways and is c...
Multilineage involvement of bone marrow (BM) hematopoiesis by the somatic KIT D816V mutation is pres...
Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mast cells ...
<div><p>Systemic Mastocytosis (SM) is a clonal disease characterized by abnormal accumulation of mas...
Mast cell disease (MCD), a proliferation of mast cells (MC), is occasionally associated with hematol...
D816V KIT mutation of bone marrow (BM) mast cells (MC) is a common feature to systemic mastocytosis ...